ISPOR - Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review

Full Text

Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review

Abstract

Authors

E. Druyts K. Thorlund C. O'Regan E. Mills

Back to Volume 16, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now